Fundraising Fox

Vita Therapeutics

Baltimore, US · Founded 2018 · Delaware corporation · 3 known investors

vitatx.com ↗
Healthtech

Founders & leadership

DF
Douglas FalkExecutive Officer, Director
VC
Vlad CoricDirector
PL
Pat LaVecchiaDirector

Investors · 3

Early Light VenturesBaltimore · $100K – $500K
Maryland TEDCOUpper Marlboro · $500K – $1.5M
Riptide VenturesBaltimore · $750Kvia Mike Leffer · inferred

Reported raises · per SEC filings

Form D private placements
▶$30.9MraisedOct 2022 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas FalkExecutive Officer, Director
  • Eva ChinDirector
  • Mark NuttallDirector
  • David ChurchillDirector
  • James PeyerDirector
  • Vlad CoricDirector
Offering amount
$30.9M
Amount sold
$30.9M
First sale
Oct 2022
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12MraisedNov 2021 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Pat LaVecchiaDirector
  • James PeyerDirector
  • Vlad CoricDirector
  • Douglas FalkExecutive Officer, Director
  • Faizzan AhmadDirector
Offering amount
$12M
Amount sold
$12M
First sale
Jun 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20MraisedJan 2021 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas FalkExecutive Officer, Director
  • Vlad CoricDirector
  • Pat LaVecchiaDirector
Offering amount
$20M
Amount sold
$20M
First sale
Jan 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.